| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3931073
Max Phase: Preclinical
Molecular Formula: C10H18N2O4
Molecular Weight: 230.26
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CNC1=N[C@@H]2[C@@H](O)[C@H](O)[C@@H]([C@H](C)O)C[C@@H]2O1
Standard InChI: InChI=1S/C10H18N2O4/c1-4(13)5-3-6-7(9(15)8(5)14)12-10(11-2)16-6/h4-9,13-15H,3H2,1-2H3,(H,11,12)/t4-,5+,6-,7-,8+,9+/m0/s1
Standard InChI Key: NFADQBQPWLAXEQ-XEFZRCJWSA-N
Associated Targets(Human)
Bifunctional protein NCOAT 460 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 230.26 | Molecular Weight (Monoisotopic): 230.1267 | AlogP: -1.55 | #Rotatable Bonds: 1 |
| Polar Surface Area: 94.31 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.14 | CX Basic pKa: 6.78 | CX LogP: -1.39 | CX LogD: -1.49 |
| Aromatic Rings: 0 | Heavy Atoms: 16 | QED Weighted: 0.44 | Np Likeness Score: 1.13 |
References
| 1. (2015) Selective glycosidase inhibitors and uses thereof, |
Source
Source(1):